Vlaeminck-Guillem V - Search Results

1

Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management.

Vlaeminck-Guillem V. Vlaeminck-Guillem V. Front Oncol. 2018 Jun 13;8:222. doi: 10.3389/fonc.2018.00222. eCollection 2018. Front Oncol. 2018. PMID: 29951375 Free PMC article. Review.

2

SRC: marker or actor in prostate cancer aggressiveness.

Vlaeminck-Guillem V, Gillet G, Rimokh R. Vlaeminck-Guillem V, et al. Front Oncol. 2014 Aug 18;4:222. doi: 10.3389/fonc.2014.00222. eCollection 2014. Front Oncol. 2014. PMID: 25184116 Free PMC article. Review.

3

Exosomes and prostate cancer management.

Vlaeminck-Guillem V. Vlaeminck-Guillem V. Semin Cancer Biol. 2022 Nov;86(Pt 1):101-111. doi: 10.1016/j.semcancer.2021.08.004. Epub 2021 Aug 9. Semin Cancer Biol. 2022. PMID: 34384877 Review.

4

When Prostate Cancer Circulates in the Bloodstream.

Vlaeminck-Guillem V. Vlaeminck-Guillem V. Diagnostics (Basel). 2015 Oct 29;5(4):428-74. doi: 10.3390/diagnostics5040428. Diagnostics (Basel). 2015. PMID: 26854164 Free PMC article. Review.

5

Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients.

Maillet D, Allioli N, Peron J, Plesa A, Decaussin-Petrucci M, Tartas S, Ruffion A, Crouzet S, Rimokh R, Gillet PG, Freyer G, Vlaeminck-Guillem V. Maillet D, et al. Eur Urol Oncol. 2021 Aug;4(4):609-617. doi: 10.1016/j.euo.2019.08.010. Epub 2019 Oct 31. Eur Urol Oncol. 2021. PMID: 31676281

6

Prognostic accuracy of prostate health index and urinary prostate cancer antigen 3 in predicting pathologic features after radical prostatectomy.

Vlaeminck-Guillem V. Vlaeminck-Guillem V. Urol Oncol. 2015 Nov;33(11):498. doi: 10.1016/j.urolonc.2015.05.027. Epub 2015 Jun 23. Urol Oncol. 2015. PMID: 26116413 No abstract available.

7

Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients.

Vlaeminck-Guillem V, Devonec M, Champetier D, Decaussi-Petrucci M, Paparel P, Perrin P, Ruffion A. Vlaeminck-Guillem V, et al. Prog Urol. 2015 Dec;25(16):1160-8, e1-8. doi: 10.1016/j.purol.2015.08.005. Epub 2015 Sep 12. Prog Urol. 2015. PMID: 26376283 English, French.

8

Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases.

Guillem P, Mintoff D, Kabbani M, Cogan E, Vlaeminck-Guillem V, Duquesne A, Benhadou F. Guillem P, et al. Among authors: vlaeminck guillem v. Front Immunol. 2022 May 26;13:883811. doi: 10.3389/fimmu.2022.883811. eCollection 2022. Front Immunol. 2022. PMID: 35720358 Free PMC article.

9

Intraperitoneal cytokine level in patients with peritoneal surface malignancies. A study of the RENAPE (French Network for Rare Peritoneal Malignancies).

Vlaeminck-Guillem V, Bienvenu J, Isaac S, Grangier B, Golfier F, Passot G, Bakrin N, Rodriguez-Lafrasse C, Gilly FN, Glehen O. Vlaeminck-Guillem V, et al. Ann Surg Oncol. 2013 Aug;20(8):2655-62. doi: 10.1245/s10434-013-2933-6. Epub 2013 Mar 22. Ann Surg Oncol. 2013. PMID: 23519518

10

[Value of urinary PCA3 test for prostate cancer diagnosis].

Vlaeminck-Guillem V, Ruffion A, Andre J. Vlaeminck-Guillem V, et al. Prog Urol. 2008 May;18(5):259-65. doi: 10.1016/j.purol.2008.03.029. Epub 2008 May 16. Prog Urol. 2008. PMID: 18538269 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page